A patient who received 35 units of short‑acting insulin (SSI) still has high blood glucose; what correction dose of rapid‑acting insulin should be given?

Immediate Management of Persistent Hyperglycemia After 35 Units of Sliding Scale Insulin

Stop using sliding scale insulin (SSI) alone immediately and transition to a structured basal-bolus insulin regimen, as SSI is ineffective and potentially dangerous for managing persistent hyperglycemia. 1, 2, 3

Why SSI Alone Has Failed

• Sliding scale insulin as monotherapy is consistently ineffective and should not be used for managing inpatient hyperglycemia, particularly when glucose remains elevated despite large correction doses 1, 2
• The fact that 35 units of correction insulin failed to achieve glycemic control indicates the patient lacks basal insulin coverage and requires a comprehensive insulin regimen 1, 3
• SSI only addresses existing hyperglycemia reactively but does not prevent ongoing gluconeogenesis or provide the basal insulin coverage needed for metabolic stability 2, 3

Immediate Action Plan

Step 1: Calculate Total Daily Dose (TDD)

• Start with 0.3-0.5 units/kg/day as the initial TDD for insulin-naive patients or those on low-dose insulin 1
• Use the lower end (0.3 units/kg) for patients at higher risk of hypoglycemia: age >65 years, renal failure, or poor oral intake 1
• If the patient was already on insulin at home at doses ≥0.6 units/kg/day, reduce the home TDD by 20% to prevent hypoglycemia during hospitalization 1

Step 2: Implement Basal-Bolus Regimen

Divide the TDD as follows: 1

• 50% as basal insulin (long-acting analog like glargine or detemir) given once or twice daily 1, 3
• 50% as prandial/correction insulin divided into three pre-meal doses of rapid-acting insulin 1, 3

For a patient with mild hyperglycemia or inconsistent oral intake, use a basal-plus approach instead: 1

• Basal insulin: 0.1-0.25 units/kg/day 1
• Correction doses of rapid-acting insulin before meals or every 6 hours if NPO 1

Step 3: Establish Correction Factor

• Use the "1700 rule" to calculate correction factor: 1700 ÷ TDD = mg/dL drop per unit of rapid-acting insulin 4
• This provides a rational, individualized correction dose rather than arbitrary SSI scales 4

Critical Pitfalls to Avoid

• Never continue SSI alone – it has been proven ineffective and is associated with worse outcomes compared to basal-bolus regimens 1, 5, 2
• Avoid premixed insulin (70/30) in the hospital setting due to unacceptably high hypoglycemia rates 1
• Do not use SSI in type 1 diabetes patients under any circumstances 1
• Monitor closely for hypoglycemia – basal-bolus regimens carry 4-6 times higher hypoglycemia risk than SSI, though they provide superior glycemic control 1

Ongoing Management

• Reassess insulin doses daily based on glucose patterns and adjust by 10-20% increments 6
• If hypoglycemia occurs without clear cause, reduce the corresponding insulin component by 10-20% 6
• Target glucose range: 140-180 mg/dL for most hospitalized patients 3, 7
• Consider adding GLP-1 RA therapy if the patient is not critically ill and has type 2 diabetes, as this may reduce insulin requirements and hypoglycemia risk 6

When to Use IV Insulin Instead

Switch to continuous IV insulin infusion if: 1, 7

• Patient is critically ill
• Glucose remains >300 mg/dL despite subcutaneous regimen
• Patient received thrombolytic therapy (stroke patients)
• Immediate post-operative period
• Extreme or persistent hyperglycemia requiring tight control for first 24-48 hours 7